Altamira Therapeutics CYTOF SEC Filings

OTC CYTOF
$0.09 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Altamira Therapeutics Ltd. (CYTOF) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
115-12GOthers0001213900-26-021580Feb 27, 2026 4:06 PM
215-12GOthers0001213900-26-021580Feb 27, 2026 4:06 PM
315-12GOthers0001213900-26-021580Feb 27, 2026 4:06 PM
46-KCurrent Report0001213900-25-082071Aug 29, 2025 7:41 AM
525-NSEOthers0001354457-25-000544Jun 17, 2025 4:17 PM
66-KCurrent Report0001213900-25-053451Jun 11, 2025 4:15 PM
7SCHEDULE 13GBeneficial Ownership Report0001172661-25-002248May 15, 2025 3:25 PM
86-KCurrent Report0001213900-25-041560May 9, 2025 4:30 PM
9SCHEDULE 13DBeneficial Ownership Report0001213900-25-039888May 6, 2025 6:39 AM
10SCHEDULE 13DBeneficial Ownership Report0001213900-25-039888May 6, 2025 6:39 AM
11SCHEDULE 13DBeneficial Ownership Report0001213900-25-039888May 6, 2025 6:39 AM
1220-FQuarterly & Annual Report0001213900-25-037199Apr 30, 2025 10:36 AM
136-KCurrent Report0001213900-25-037097Apr 30, 2025 8:00 AM
14S-8Prospectus0001213900-25-029036Apr 4, 2025 4:31 PM
156-KCurrent Report0001213900-25-022236Mar 10, 2025 4:30 PM
16SCHEDULE 13GBeneficial Ownership Report0001172661-25-001302Feb 14, 2025 5:41 PM
176-KCurrent Report0001213900-24-110771Dec 20, 2024 8:00 AM
18SC 13GBeneficial Ownership Report0001172661-24-005081Nov 14, 2024 3:27 PM
196-KCurrent Report0001213900-24-085537Oct 4, 2024 4:01 PM
206-KCurrent Report0001213900-24-081199Sep 24, 2024 8:15 AM
216-KCurrent Report0001213900-24-080300Sep 19, 2024 4:17 PM
22424B4Prospectus0001213900-24-079889Sep 18, 2024 4:19 PM
23EFFECTOthers9999999995-24-002863Sep 17, 2024 12:15 AM
24CORRESPOthers0001213900-24-078897Sep 16, 2024 1:58 PM
25CORRESPOthers0001213900-24-078894Sep 16, 2024 1:57 PM
26F-1Prospectus0001213900-24-078891Sep 16, 2024 1:55 PM
27F-1Prospectus0001213900-24-078764Sep 16, 2024 9:29 AM
28UPLOADOthers0000000000-24-009798Aug 28, 2024 12:36 PM
29F-1Prospectus0001213900-24-071896Aug 22, 2024 4:53 PM
30EFFECTOthers9999999995-24-002147Jul 12, 2024 12:15 AM
31POS AMOthers0001213900-24-059862Jul 8, 2024 5:17 PM
3220-FQuarterly & Annual Report0001213900-24-057548Jul 1, 2024 7:08 AM
336-KCurrent Report0001213900-24-044325May 16, 2024 4:15 PM
3420-FQuarterly & Annual Report0001213900-24-034940Apr 22, 2024 4:31 PM
35EFFECTOthers9999999995-24-001012Apr 17, 2024 12:15 AM
36424B4Prospectus0001213900-24-033817Apr 17, 2024 4:20 PM
376-KCurrent Report0001213900-24-033500Apr 16, 2024 5:00 PM
38UPLOADOthers0000000000-24-004084Apr 16, 2024 2:39 PM
39CORRESPOthers0001213900-24-033266Apr 16, 2024 12:11 PM
406-KCurrent Report0001213900-24-031741Apr 10, 2024 8:30 AM
41S-8Prospectus0001213900-24-031738Apr 10, 2024 8:15 AM
42F-1Prospectus0001213900-24-031737Apr 10, 2024 8:15 AM
4320-FQuarterly & Annual Report0001213900-24-031734Apr 10, 2024 8:00 AM
44SC 13DBeneficial Ownership Report0001213900-24-022034Mar 13, 2024 11:03 AM
45424B4Prospectus0001213900-24-005353Jan 22, 2024 5:02 PM
46EFFECTOthers9999999995-24-000160Jan 19, 2024 12:15 AM
476-KCurrent Report0001213900-24-004906Jan 19, 2024 4:45 PM
48424B5Prospectus0001213900-24-004900Jan 19, 2024 4:40 PM
496-KCurrent Report0001213900-24-004886Jan 19, 2024 4:30 PM
50CORRESPOthers0001213900-24-004245Jan 17, 2024 7:13 PM
...

Altamira Therapeutics Ltd. SEC Filings API

Pull Altamira Therapeutics Ltd.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=CYTOF&formtype=10-K,10-Q&api_key=YOUR_API_KEY